KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Travere Therapeutics (TVTX) Interest & Investment Income (2016 - 2025)

Travere Therapeutics' Interest & Investment Income history spans 13 years, with the latest figure at $2.6 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 31.7% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $12.7 million, down 28.6%, while the annual FY2025 figure was $12.7 million, 28.6% down from the prior year.
  • Interest & Investment Income reached $2.6 million in Q4 2025 per TVTX's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $7.2 million in Q4 2023 to a low of -$4.9 million in Q3 2021.
  • Average Interest & Investment Income over 5 years is $1.7 million, with a median of $3.1 million recorded in 2022.
  • The largest YoY upside for Interest & Investment Income was 555.75% in 2023 against a maximum downside of 1125.18% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at -$4.6 million in 2021, then surged by 167.57% to $3.1 million in 2022, then surged by 129.6% to $7.2 million in 2023, then tumbled by 46.94% to $3.8 million in 2024, then plummeted by 31.7% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Interest & Investment Income are $2.6 million (Q4 2025), $3.0 million (Q3 2025), and $3.3 million (Q2 2025).